Back
Edgewise Therapeutics 10K Form
Buy
53
EWTX
Edgewise Therapeutics
Last Price:
16.72
Seasonality Move:
-4.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EWTX News And Ratings
See the #1 stock for the next 7 days that we like better than EWTX
EWTX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-28.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.73 |
| Price / Book: | 2.98 |
Profitability
| EPS (TTM): | -1.55000 |
|---|---|
| Net Income (TTM): | $-105.85M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Edgewise Therapeutics Earnings Forecast
Key Edgewise Therapeutics Financial Ratios
- Per Share Earnings over the last 5 years have been positive in 1 years.
Edgewise Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | EWTX |
| Website: | edgewisetx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
EWTX Technical Analysis vs Fundamental Analysis
Buy
53
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a Buy
The current Edgewise Therapeutics [EWTX] share price is $17.05. The Score for EWTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.